Back
Axsome Therapeutics Stock Price Chart

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
33
AXSM
Axsome Therapeutics
Last Price:
$104.60
Seasonality Move:
11.24%
7 Day Trial
ALL ACCESS PASS
$
7

10 Best Stocks to Own in 2025
Get your copy now FREE!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.
Axsome Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.79 | Sell |
20-day SMA: | 108.3 | Sell |
50-day SMA: | 109.42 | Sell |
200-day SMA: | 100.56 | Buy |
8-day EMA: | 105.22 | Sell |
20-day EMA: | 106.74 | Sell |
50-day EMA: | 108.66 | Sell |
200-day EMA: | 101.47 | Buy |
Axsome Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.35 | Sell |
Relative Strength Index (14 RSI): | 40.23 | Sell |
Chaikin Money Flow: | -299330 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.62 - 111.3) | Sell |
Bollinger Bands (100): | (96.55 - 123.39) | Sell |
Axsome Therapeutics Technical Analysis
May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 102.99 while AXSM 8-day simple moving average is 105.79, which is a Sell signal.
-
The stock price of AXSM is 102.99 while Axsome Therapeutics 20-day SMA is 108.30, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 109.42 while AXSM share price is 102.99, making it a Sell technically.
-
AXSM stock price is 102.99 and Axsome Therapeutics 200-day simple moving average is 100.56, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
33
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $102.99. The Score for AXSM is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.1B
Price in USD:
102.99
Share Volume:
605K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
33
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 102.99 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 102.99 while AXSM 8-day exponential moving average is 105.22, which is a Sell signal.
-
The stock price of AXSM is 102.99 while Axsome Therapeutics 20-day EMA is 106.74, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 108.66 while AXSM share price is 102.99, making it a Sell technically.
-
AXSM stock price is 102.99 and Axsome Therapeutics 200-day simple moving average is 101.47, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.99 per share, an increase this year of $1.51 per share, and an increase next year of $4.87 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is -1.35, suggesting Axsome Therapeutics is a Sell
-
Axsome Therapeutics Relative Strength Index (RSI) is 40.23, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (104.62 - 111.3), which suggest Axsome Therapeutics is a Sell
-
The Bollinger Bands (100) for Axsome Therapeutics is (96.55 - 123.39), which suggest Axsome Therapeutics is a Sell
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.